No Carolina / NY / Florida
Ph: 561.316.3330

Sectra Signs Enterprise Imaging Contract with One of the Larger Multi-Regional Healthcare Systems in the United States

Summation

  • The contracted order value for the implementation and use of subscription service until 2033 initially amounts to 227 million dollars, if the full term of the contract is realized, and does not include   expansion plans into additional imaging service lines including, Pathology, Cardiology and Orthopaedics.
  • We are thrilled for the opportunity to help this health leader execute a long-term multi-departmental imaging strategy as they focus on growing quality and sustainability in their health system.
  • “Regardless of size or infrastructure challenges, Sectra is focused on driving down the costs and complexity of traditional on-premise solutions with highly scalable, high-performance enterprise imaging solutions as a service.

nternational medical imaging IT and cybersecurity company Sectra (STO: SECT B) will provide Sectra One Cloud, its enterprise imaging cloud subscription service for diagnostic imaging, to a US-based health system serving a multi-million strong patient community.

Sectra will, as the sole imaging IT provider oversee and deliver the end-to-end infrastructure through a turnkey, fully managed SaaS agreement. Expanding on Sectra’s previously implemented solution for Ophthalmology this enterprise imaging solution will initially be leveraged by the health system’s Radiology service teams and over time into additional imaging service lines including Pathology, Cardiology and Orthopaedics. The cloud solution will be operated in Microsoft Azure as part of a sub-contract agreement with Microsoft managed by Sectra.

“Health systems are under tremendous pressure to maintain patient excellence while balancing growing financial and staffing concerns,” shared Isaac Zaworski, the President of Sectra, Inc. “Regardless of size or infrastructure challenges, Sectra is focused on driving down the costs and complexity of traditional on-premise solutions with highly scalable, high-performance enterprise imaging solutions as a service. We are thrilled for the opportunity to help this health leader execute a long-term multi-departmental imaging strategy as they focus on growing quality and sustainability in their health system.”

The contracted order value for the implementation and use of subscription service until 2033 initially amounts to 227 million dollars, if the full term of the contract is realized, and does not include   expansion plans into additional imaging service lines including, Pathology, Cardiology and Orthopaedics. The agreement was signed in June 2023 and is recognized in order bookings for the first quarter of the 2023/2024 fiscal year.

Sectra One Cloud

More News

Abu Dhabi Issues First BioTech Inventor-Class Golden Visa to Catalyze “Made-In-Abu-Dhabi IP” to Rockefeller University Inventor Dr Kambiz Shekdar, PhD

Dr Kambiz Shekdar said: "I gratefully take this opportunity as my solemn commitment to help build up the BioTech sector in Abu Dhabi with the same home-grown can-do-and-have-done record of accomplishment demonstrated by Emirati leadership, its people, and nation, and to do so collegially with the best of the best of the world's human capital across frontier technologies who, like myself, are drawn to the UAE with the thirst to pioneer and build better like only possible in the red-hot entrepreneurial climate of the UAE."

Activation Capital Introduces ‘Frontier BioHealth’ to Catalyze Life Science Startups

"We celebrate the growing base of research and technological advances within the region's health and life sciences sector," said Chandra Briggman, President and CEO of Activation Capital.

Moleculin Announces Commencement of NIH-Funded Phase 2 Clinical Trial of STAT3 Inhibitor for the Treatment of Glioblastoma (NU 21C06)

Investigator-Initiated Phase 2 study is being conducted at Northwestern University in cooperation with Moleculin. Trial combines WP1066 and radiation, which demonstrated both significant therapeutic response and immune "memory" in glioblastoma animal models

By using this website you agree to accept Medical Device News Magazine Privacy Policy